Literature DB >> 9842977

Pharmacokinetic parameters and killing rates in serum of volunteers receiving amoxicillin, cefadroxil or cefixime alone or associated with niflumic acid or paracetamol.

H Carsenti-Etesse1, R Farinotti, J Durant, P M Roger, F De Salvador, E Bernard, B Rouveix, P Dellamonica.   

Abstract

Pharmacokinetic parameters and killing rates in serum of volunteers receiving amoxicillin, cefadroxil or cefixime alone or associated with niflumic acid or paracetamol were studied. Niflumic acid (250 mg) or analgesic and antipyretic drugs such as paracetamol (500 mg) are often combined with antibiotics to avoid inflammation and pain in acute ear, nose and throat diseases. Pharmacokinetic interactions between these two classes of drugs have been described in experimental models, and exceptionally in humans. The aim of the present investigation was to study the interactions of these two drugs with three antibiotics (amoxicillin 500 mg x 2, cefadroxil 500 mg x 2, cefixime 200 mg and one placebo capsule) on pharmacodynamic parameters and on rate of killing in the serum of six healthy volunteers receiving the antibiotic associated or not with the product in a randomized cross-over double-blind trial. The bacteria most often involved in sinusitis, bronchitis and otitis media (Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus) three target diseases for oral cephalosporins and amoxicillin, were chosen for bacteriological study. Blood samples were obtained at 0.25, 0.50, 1, 1.5, 2, 4, 6 and 12 h after oral administration of antibiotics alone or associated with the drugs. There was a wash-out period of at least 1 week between the eleven sequences. Antibiotics were measured by two methods: bioassay and high performance liquid chromatography (HPLC). All serum samples obtained at peak level, 4 and 6 h were tested for killing rate. Area under the time kill curve was calculated by the trapezoidal rule method and relative bioactivity in percent was defined as follows: (AUC control - AUC test)/AUC control x 100. No pharmacokinetic interaction was found in the AUC and T1/2 of the plasma concentrations of the antibiotics or associated with the drugs, regardless of dose, as determined by HPLC or microbiological assay. For these beta-lactam antibiotics killing rate was found to be time-dependent. Bactericidal activity was improved on H. influenzae when cefixime was associated with niflumic acid and became concentration-dependent. A significant concentration relation was also found with niflumic acid or paracetamol associated with cefixime on Strep. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9842977     DOI: 10.1007/BF03192294

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  14 in total

Review 1.  High-performance liquid chromatography of antibiotics.

Authors:  F Jehl; C Gallion; H Monteil
Journal:  J Chromatogr       Date:  1990-10-12

Review 2.  [Antibiotics and anti-inflammatory agents: drug interactions].

Authors:  C Carbon
Journal:  Pathol Biol (Paris)       Date:  1990-04

3.  Piroxicam treatment protects mice from lethal pulmonary challenge with Pseudomonas aeruginosa.

Authors:  D O Sordelli; M C Cerquetti; P A Fontán; R P Meiss
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

4.  Double-blind, placebo-controlled multicentre trial of the efficacy and tolerance of morniflumate suppositories in the treatment of tonsillitis in children.

Authors:  Y Manach; A Ditisheim
Journal:  J Int Med Res       Date:  1990 Jan-Feb       Impact factor: 1.671

5.  Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.

Authors:  V Joly; B Pangon; N Brion; J M Vallois; C Carbon
Journal:  J Pharmacol Exp Ther       Date:  1988-08       Impact factor: 4.030

6.  Regulation of ompF porin expression by salicylate in Escherichia coli.

Authors:  J L Rosner; T J Chai; J Foulds
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

7.  Transient carbapenem resistance induced by salicylate in Pseudomonas aeruginosa associated with suppression of outer membrane protein D2 synthesis.

Authors:  Y Sumita; M Fukasawa
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein.

Authors:  J L Burns; D K Clark
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

9.  Modification of cefixime bioavailability by nifedipine in humans: involvement of the dipeptide carrier system.

Authors:  C Duverne; A Bouten; A Deslandes; J F Westphal; J H Trouvin; R Farinotti; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

10.  Pharmacokinetic and bacteriological study of cefadroxil-salicylate and josamycin-salicylate drug regimens.

Authors:  P Dellamonica; R Garraffo; H Etesse-Carsenti; E Bernard; V Mondain
Journal:  Int J Clin Pharmacol Res       Date:  1993
View more
  2 in total

1.  Pharmacokinetics of oleandomycin in dogs after intravenous or oral administration alone and after pretreatment with metamizole or dexamethasone.

Authors:  A Milanova; L Lashev
Journal:  Vet Res Commun       Date:  2002-01       Impact factor: 2.459

Review 2.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.